Residency

Pharmaceutical industry support prevalent in GME

Residency Program Insider, March 2, 2010

Want to receive articles like this one in your inbox? Subscribe to Residency Program Insider!

A survey of internal medicine residency programs shows that many program directors accept funding from pharmaceutical companies even though they would prefer not to, according to a JAMA media press release.

The study, published in the Feb. 22 Archives of Internal Medicine, found that of the 236 program directors who responded to the survey:
72% believe that pharmaceutical support is undesirable
55.9% report accepting pharmaceutical industry support for food for conferences (90.9%), educational materials (83.3%), office supplies (68.9%), and drug samples (57.6%)
50% report that the final decision to accept industry support rested with them, whereas the other half named another final decisionmaker, such as a hospital administrator, chair of medicine, or institutional oversight committee.

Read more about the study from the Archives of Internal Medicine.



Want to receive articles like this one in your inbox? Subscribe to Residency Program Insider!

Most Popular